nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function
|
Hunt, William R. |
|
2016 |
15 |
5 |
p. 681-688 8 p. |
artikel |
2 |
Are CF carriers predisposed to asthma?
|
Corvol, H. |
|
2016 |
15 |
5 |
p. 555-556 2 p. |
artikel |
3 |
Challenge for a new era—importance of ensuring accuracy of genotype in cystic fibrosis registries
|
Hartley, Claire L. |
|
2016 |
15 |
5 |
p. e50-e51 nvt p. |
artikel |
4 |
Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection
|
Esther Jr., Charles R. |
|
2016 |
15 |
5 |
p. e45-e49 nvt p. |
artikel |
5 |
Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis
|
Taylor, C.J. |
|
2016 |
15 |
5 |
p. 675-680 6 p. |
artikel |
6 |
Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug”
|
Rachul, Christen |
|
2016 |
15 |
5 |
p. 624-629 6 p. |
artikel |
7 |
Corrigendum to “Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study” [J Cyst Fibros (2015) 632–638]
|
Thompson, V. |
|
2016 |
15 |
5 |
p. e54-e55 nvt p. |
artikel |
8 |
Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis
|
Bos, Aukje C. |
|
2016 |
15 |
5 |
p. 645-651 7 p. |
artikel |
9 |
Disease disclosure in individuals with cystic fibrosis: Association with psychosocial and health outcomes
|
Borschuk, Adrienne P. |
|
2016 |
15 |
5 |
p. 696-702 7 p. |
artikel |
10 |
Editorial Board
|
|
|
2016 |
15 |
5 |
p. ii- 1 p. |
artikel |
11 |
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF)
|
Viviani, Laura |
|
2016 |
15 |
5 |
p. 619-623 5 p. |
artikel |
12 |
Episodic oral antibiotic use in CF: Discordance between the electronic medical record and self-report
|
Caverly, Lindsay J. |
|
2016 |
15 |
5 |
p. 630-633 4 p. |
artikel |
13 |
Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis
|
Chadha, Ashley D. |
|
2016 |
15 |
5 |
p. 597-604 8 p. |
artikel |
14 |
Insulin secretion abnormalities in patients with cystic fibrosis
|
Schnyder, Marie-Angela |
|
2016 |
15 |
5 |
p. e52-e53 nvt p. |
artikel |
15 |
Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients
|
Sans-Serramitjana, E. |
|
2016 |
15 |
5 |
p. 611-618 8 p. |
artikel |
16 |
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis
|
Zampoli, Marco |
|
2016 |
15 |
5 |
p. 605-610 6 p. |
artikel |
17 |
Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis
|
Tridello, Gloria |
|
2016 |
15 |
5 |
p. 579-582 4 p. |
artikel |
18 |
News
|
|
|
2016 |
15 |
5 |
p. 561-562 2 p. |
artikel |
19 |
Non-allergic asthma as a CFTR-related disorder
|
Schulz, Angela |
|
2016 |
15 |
5 |
p. 641-644 4 p. |
artikel |
20 |
Ode to the exocrine pancreas
|
Coffey, Michael J. |
|
2016 |
15 |
5 |
p. 557-558 2 p. |
artikel |
21 |
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients
|
Thompson, R. Zachary |
|
2016 |
15 |
5 |
p. 660-663 4 p. |
artikel |
22 |
Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients
|
Walkowiak, Jarosław |
|
2016 |
15 |
5 |
p. 664-668 5 p. |
artikel |
23 |
Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations
|
Dekkers, Johanna F. |
|
2016 |
15 |
5 |
p. 568-578 11 p. |
artikel |
24 |
Preliminary report of the 13C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis
|
van der Haak, Natalie |
|
2016 |
15 |
5 |
p. 669-674 6 p. |
artikel |
25 |
Psychological resilience and intolerance of uncertainty in coping with cystic fibrosis
|
Mitmansgruber, Horst |
|
2016 |
15 |
5 |
p. 689-695 7 p. |
artikel |
26 |
Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma
|
Levine, Hagit |
|
2016 |
15 |
5 |
p. 652-659 8 p. |
artikel |
27 |
Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
|
Nielsen, Anne Orholm |
|
2016 |
15 |
5 |
p. 563-567 5 p. |
artikel |
28 |
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection
|
Elborn, J. Stuart |
|
2016 |
15 |
5 |
p. 634-640 7 p. |
artikel |
29 |
The power of mental adaptation to genetic abnormality
|
Goldbeck, Lutz |
|
2016 |
15 |
5 |
p. 559-560 2 p. |
artikel |
30 |
The role of basophil activation test in allergic bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization in cystic fibrosis patients
|
Katelari, Anna |
|
2016 |
15 |
5 |
p. 587-596 10 p. |
artikel |
31 |
YKL-40 as marker of severe lung disease in cystic fibrosis patients
|
Leonardi, Salvatore |
|
2016 |
15 |
5 |
p. 583-586 4 p. |
artikel |